Corbus Pharmaceuticals Holdings Inc. stock rises on Wednesday and outperforms the market



[ad_1]

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP,
+ 10.88%
jumped 10.88% to $ 3.42 on Wednesday, on what turned out to be a mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA,
+ 0.20%
up 0.20% to 31,437.80 and the NASDAQ COMP Composite Index,
-0.25%
down 0.25% to 13,972.53. It was the share’s third consecutive day of gains. Corbus Pharmaceuticals Holdings Inc. closed $ 6.37 below its 52-week high ($ 9.78), which the company hit on August 31.

The stock outperformed some of its rivals on Wednesday, as Fate Therapeutics Inc. FATE,
-1.91%
fell 1.91% to $ 103.31, Vanda Pharmaceuticals Inc. VNDA,
-0.58%
fell 0.58% to $ 15.41, and Viking Therapeutics Inc. VKTX,
-2.09%
fell 2.09% to $ 8.89. Trade volume (66.0 M) eclipsed its 50-day average volume of 12.8 Mio.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

[ad_2]

Source link